The average one-year price target for Opus Genetics (NASDAQCM:IRD) has been revised to $12.98 / share. This is an increase of 21.47% from the prior estimate of $10.68 dated August 25, 2026. These ...
Radhika Rampat, MBBS, FRCOphth, discusses how AI is already shaping intraocular lens selection and keratoconus screening, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results